PATENT CLAIM ANALYSIS

Application Number: 15948771
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "178000"]

Abstract:
Disclosed herein are emulsions comprising testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. The compositions are useful for treating keratoconjunctivitis sicca and meibomian gland disease.

Claim (Index 3):
The method of  claim 2 , wherein the testosterone is present in the composition at a concentration of between about 0.01% (w/w) and about 0.5% (w/w).

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.22581
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14216464', '13357779', '14840276', '13378335', '15078377']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7622476023887585
- 35 USC 102 Novelty (BERT): 0.5301846439828651
- Combined Prediction Score: 0.7390413065481692
- Mean Citation Score: 208.993324
- Max Citation Score: 280.71918
- Similarity Product: 206.273853665278

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test